The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The optimized HLH inflammatory index: A novel prognostic tool for newly diagnosed patients with diffuse large B-cell lymphoma—Discovery and validation.
 
Adi Zoref Lorenz
Consulting or Advisory Role - SOBI
Travel, Accommodations, Expenses - SOBI
 
Elliot Cahn
No Relationships to Disclose
 
Eric Mou
Consulting or Advisory Role - Abbvie
 
Yucai Wang
Employment - Merck (I)
Stock and Other Ownership Interests - Merck (I)
Honoraria - Kite, a Gilead company (Inst)
Consulting or Advisory Role - Abbvie; AstraZeneca (Inst); BeiGene (Inst); Genmab (Inst); Incyte (Inst); Innocare (Inst); Janssen (Inst); Kite, a Gilead company (Inst); Lilly (Inst); Loxo (Inst); TG Therapeutics (Inst)
Research Funding - Abbvie (Inst); BeiGene (Inst); Genentech (Inst); Genmab (Inst); Incyte (Inst); InnoCare (Inst); Lilly (Inst); Loxo (Inst); Merck (Inst); MorphoSys (Inst); Novartis (Inst)
 
Matthew Maurer
Employment - Exact Sciences (I)
Stock and Other Ownership Interests - Exact Sciences (I)
Consulting or Advisory Role - AstraZeneca; BMS (Inst)
Research Funding - Bristol-Myers Squibb (Inst); Genmab (Inst); Roche/Genentech (Inst)
 
Andew Feldman
No Relationships to Disclose
 
Brianna Negaard
Employment - Mayo Clinic
 
Raphael Mwangi
No Relationships to Disclose
 
Gilad Itchaki
No Relationships to Disclose
 
Grzegorz Nowakowski
Consulting or Advisory Role - Abbvie; Bantam Pharmaceutical; Bristol-Myers Squibb/Celgene; Celgene (Inst); Debiopharm Group; Genentech (Inst); Genmab; Karyopharm Therapeutics; Kite/Gilead; kymera; MorphoSys (Inst); Roche Pharma AG (Inst); Ryvu Therapeutics; Selvita; TG Therapeutics
Research Funding - Celgene (Inst); MorphoSys (Inst); NanoString Technologies (Inst)
 
Thomas Habermann
Consulting or Advisory Role - Celgene; Kite/Gilead
Research Funding - Genentech (Inst)
(OPTIONAL) Uncompensated Relationships - BeiGene; Incyte; Loxo/Lilly; MorphoSys; Seagen; Tessa Therapeutics
 
Brian Link
Consulting or Advisory Role - Genentech/Roche; MEI Pharma
Research Funding - Genentech/Abbvie (Inst); Genmab (Inst); Pharmacyclics/Janssen (Inst)
Expert Testimony - Amgen
 
Stephen Ansell
Honoraria - Answers in CME; Medscape; Research to Practice; WebMD
Research Funding - ADC Therapeutics (Inst); Affimed Therapeutics (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Pfizer (Inst); Regeneron (Inst); Seagen (Inst); Step Pharma (Inst); Takeda (Inst)
 
Anne Novak
Research Funding - Bristol-Myers Squibb
 
Gaurav Goyal
Consulting or Advisory Role - Opna Bio; Recordati; Seagen; SOBI
Patents, Royalties, Other Intellectual Property - Royalties from Uptodate
 
Thomas Witzig
Consulting or Advisory Role - Tornado Therapeutics
Research Funding - Acerta Pharma (Inst); Acrotech Biopharma (Inst); Celgene (Inst); Karyopharm Therapeutics (Inst); Kura Oncology (Inst)
Patents, Royalties, Other Intellectual Property - I am co-inventor on a patent application filed by Mayo Clinic and pending on the combination of CRM1 inhibitors with salicylates. Please note - simply filed - not even close to being granted. (Inst)
 
James Cerhan
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene (Inst); Protagonist Therapeutics
Research Funding - Celgene (Inst); Genentech (Inst); Genentech (Inst); Genentech (Inst); Genmab (Inst)
(OPTIONAL) Uncompensated Relationships - Regeneron (Inst)
 
Michael Jordan
Consulting or Advisory Role - SOBI
Research Funding - SOBI